Emergent BioSolutions Inc. — Director's Dealing 2016

Mar 31, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2016-03-30

Reporting Person: Havey Adam (EVP, Biodefense Divison)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-30	Common Stock	M	3467	$15.91	Acquired	40972	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-03-30	Stock Option	$15.91	M	3467	Acquired	2017-03-08	Common Stock (3467)	Direct

Footnotes

F1: Consists of an option granted under the company's stock incentive plan on March 9, 2010.

F2: The option vested in three equal installments in March 2011, 2012 and 2013.